News + Filings Transactions
|
Bonita David P
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/15/2023 | Acutus Medical, Inc. | AFIB | Grant | | 8.4k | $0.00 | $0 | | 06/15/2023 |
06/15/2023 | Acutus Medical, Inc. | AFIB | Grant | | 19.6k | $0.83 | $16.4k | | 06/15/2023 |
06/08/2023 | Repare Therapeutics Inc. | RPTX | Grant | Stock Option (right to buy) | 27.2k | $11.66 | $317.2k | | 06/08/2023 |
06/06/2023 | Third Harmonic Bio, Inc. | | Grant | Stock Option (right to buy) | 16.2k | $5.03 | $81.7k | | 06/06/2023 |
05/22/2023 | Prelude Therapeutics Inc | PRLD | Purchase | Common Stock | 869.6k | $5.75 | $5M | See footnotes | 05/22/2023 |
03/06/2023 | Third Harmonic Bio, Inc. | | Disposition | Employee Stock Option (right to buy) | 13.7k | $17.83 | $243.7k | | 03/06/2023 |
03/06/2023 | Third Harmonic Bio, Inc. | | Grant | Employee Stock Option (right to buy) | 13.7k | $4.20 | $57.4k | | 03/06/2023 |
11/25/2022 | Tricida, Inc. | TCDA | Sale | Common Stock | 3.6M | $0.22 | $798.4k | See Footnotes | 11/22/2022 |
11/23/2022 | Tricida, Inc. | TCDA | Sale | Common Stock | 5.6M | $0.21 | $1.2M | See Footnotes | 11/22/2022 |
11/22/2022 | Tricida, Inc. | TCDA | Sale | Common Stock | 1M | $0.22 | $227.6k | See Footnotes | 11/22/2022 |
09/19/2022 | Third Harmonic Bio, Inc. | | Conversion | Common Stock | 5.5M | $0.00 | $0 | See Footnote | 09/19/2022 |
09/19/2022 | Third Harmonic Bio, Inc. | | Purchase | Common Stock | 300k | $17.00 | $5.1M | See Footnote | 09/19/2022 |
09/19/2022 | Third Harmonic Bio, Inc. | | Conversion | Series A-2 Preferred Stock | 8.6M | $0.00 | $0 | See Footnote | 09/19/2022 |
09/19/2022 | Third Harmonic Bio, Inc. | | Conversion | Series A-3 Preferred Stock | 2.4M | $0.00 | $0 | See Footnote | 09/19/2022 |
09/19/2022 | Third Harmonic Bio, Inc. | | Conversion | Series B Preferred Stock | 1.3M | $0.00 | $0 | See Footnote | 09/19/2022 |
06/24/2022 | Ikena Oncology, Inc. | | Purchase | Common Stock | 66k | $4.37 | $288.3k | See Footnotes | 06/22/2022 |
06/24/2022 | Ikena Oncology, Inc. | | Purchase | Common Stock | 96k | $5.37 | $515.7k | See Footnotes | 06/22/2022 |
06/23/2022 | Ikena Oncology, Inc. | | Purchase | Common Stock | 23.4k | $3.71 | $86.9k | See Footnotes | 06/22/2022 |
06/22/2022 | Ikena Oncology, Inc. | | Purchase | Common Stock | 66.8k | $3.55 | $237.2k | See Footnotes | 06/22/2022 |
06/17/2022 | Prelude Therapeutics Inc | PRLD | Grant | Director Stock Option (Right to Buy) | 34.3k | $4.74 | $162.6k | | 06/17/2022 |
06/16/2022 | Acutus Medical, Inc. | AFIB | Grant | Common Stock | 8.4k | $0.00 | $0 | | 06/16/2022 |
06/16/2022 | Acutus Medical, Inc. | AFIB | Grant | Stock Options (Right to Buy) | 19.6k | $0.50 | $9.9k | | 06/16/2022 |
06/15/2022 | Tricida, Inc. | TCDA | Grant | Stock Option (right to buy) | 27.2k | $9.87 | $268.5k | | 06/15/2022 |
06/09/2022 | Ikena Oncology, Inc. | | Grant | Stock Option (Right to Buy) | 13.4k | $4.85 | $65.1k | | 06/09/2022 |
06/02/2022 | Enliven Therapeutics, Inc. | IMRA | Grant | Stock Options (Right to Buy) | 8.5k | $1.07 | $9.1k | | 06/02/2022 |
05/13/2022 | Repare Therapeutics Inc. | RPTX | Grant | Stock Option (right to buy) | 49k | $9.55 | $468k | | 05/13/2022 |
12/21/2021 | Ikena Oncology, Inc. | | Grant | Stock Option (Right to Buy) | 13.4k | $14.92 | $200.2k | | 12/21/2021 |
11/15/2021 | Tricida, Inc. | TCDA | Grant | Common Stock | 666.7k | $6.00 | $4M | By OrbiMed Private Investments V, LP | 11/15/2021 |
11/15/2021 | Tricida, Inc. | TCDA | Grant | Common Warrants | 666.7k | $11.00 | $7.3M | By OrbiMed Private Investments V, LP | 11/15/2021 |
09/07/2021 | Repare Therapeutics Inc. | RPTX | Sale | Common Stock | 861 | $33.93 | $29.2k | See Footnotes | 09/03/2021 |
09/07/2021 | Repare Therapeutics Inc. | RPTX | Sale | Common Stock | 26 | $33.93 | $882.2 | See Footnotes | 09/03/2021 |
09/03/2021 | Repare Therapeutics Inc. | RPTX | Sale | Common Stock | 7k | $34.00 | $237.5k | See Footnotes | 09/03/2021 |
09/03/2021 | Repare Therapeutics Inc. | RPTX | Sale | Common Stock | 212 | $34.00 | $7.2k | See Footnotes | 09/03/2021 |
09/02/2021 | Repare Therapeutics Inc. | RPTX | Sale | Common Stock | 15.9k | $34.24 | $545.8k | See Footnotes | 08/31/2021 |
09/02/2021 | Repare Therapeutics Inc. | RPTX | Sale | Common Stock | 483 | $34.24 | $16.5k | See Footnotes | 08/31/2021 |
|
|